Solid Tumor Malignancy
Oncology·MeSH: Acrocephalosyndactylia
1 drug in development·1 company·2 clinical trials
Drug Pipeline by Phase
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| mrtx1719 | Mirati Therapeutics, Inc. (MRTX) |
Frequently asked questions
How many drugs are in development for Solid Tumor Malignancy?
BioSniper tracks 1 drug in development for Solid Tumor Malignancy across 1 company.
How many clinical trials target Solid Tumor Malignancy?
There are 2 clinical trials targeting Solid Tumor Malignancy tracked by BioSniper.
Deep-dive into Solid Tumor Malignancy
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis